From Name:
From Email:
To Name:
To Email:

Optional Message:


1st Patient Enrolled in DAPT Duration Trial

from Healio

Abbott recently announced the first patient enrollment for a trial evaluating shorter-duration dual antiplatelet therapy (DAPT) in patients at high risk for bleeding after everolimus-eluting coronary stent implantation. Typically, patients are prescribed DAPT for one year after receiving a stent. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063